Worth reading
51Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
326
Share acquisition rights (100 shares per right)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock compensation-type stock options (stock acquisition rights)
発行・処分する株式数
32,600 common shares (326 share acquisition rights, 100 shares per right)
Intended allottee
Name Directors of the Company (excluding outside directors and directors who are Audit & Supervisory Committee members) / Number of Employees 3 / Number of stock acquisition rights 71 rights, Name Directors of the Company's subsidiaries (excluding outside directors, Audit & Supervisory Board members and non-executive directors) / Number of Employees 21 / Number of stock acquisition rights 255 rights
An amount calculated by multiplying the fair value per share calculated using the Black-Scholes model on the allotment date by the number of shares underlying the grant
Amount of funds to be raised
No cash payment will be made; the amount will be offset against compensation receivables. Estimated net proceeds: not disclosed
Total Stock-Based Compensation
Compensation receivables equivalent to the payment amount for the share acquisition rights. Amount: not disclosed
Terms of the stock acquisition rights
Exercise price
¥1 per share. Adjustment provisions and floor: Not disclosed
Exercise period
Start Date 25 April 2026 / End date 24 April 2056
Number of Stock Acquisition Rights
Total number issued 326 (the number scheduled to be allotted; this may decrease if applications are not submitted, among other circumstances) / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If the rights become unexercisable before exercise, or if a proposal for a merger, company split, share exchange, share transfer or similar transaction is approved, among other circumstances
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Transfer restriction period
not disclosed (approval from the Company's Board of Directors is required for any transfer or acquisition by transfer)
Conditions for lifting transfer restrictions
The rights may be exercised only within 10 days from the day following the date on which the holder loses all positions as a director. Other conditions are governed by the share acquisition rights allotment agreement.
Categories and Number of Persons Covered
Category Directors of the Company (excluding outside directors and directors who are Audit & Supervisory Committee members) / Number of Employees 3 / Number of allocated stock acquisition rights 71 rights, Category Directors of the Company's subsidiaries (excluding outside directors, Audit & Supervisory Board members and non-executive directors) / Number of Employees 21 / Number of allocated stock acquisition rights 255 rights
Basis for determining the amount to be paid
Fair value per share calculated using the Black-Scholes model on the allotment date. The periods used for the closing price and average share price, and the discount and premium rates: not disclosed
Procedures under the Corporate Code of Conduct
Resolved at the Board of Directors meeting held on 8 April 2026. Obtaining an opinion from an independent third party and confirming shareholder intent: not disclosed
Impact on Business Performance
The purpose is to strengthen incentives to improve long-term business performance and corporate value. Impact on business performance and financial results: not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock compensation-type stock options (stock acquisition rights) |
| Number of shares to be issued or disposed of | 32,600 common shares (326 share acquisition rights, 100 shares per right) |
| Issue price and disposal price | An amount calculated by multiplying the fair value per share calculated using the Black-Scholes model on the allotment date by the number of shares underlying the grant |
| Amount of funds to be raised | No cash payment will be made; the amount will be offset against compensation receivables. Estimated net proceeds: not disclosed |
| Intended allottee | Name Directors of the Company (excluding outside directors and directors who are Audit & Supervisory Committee members) / Number of Employees 3 / Number of stock acquisition rights 71 rights, Name Directors of the Company's subsidiaries (excluding outside directors, Audit & Supervisory Board members and non-executive directors) / Number of Employees 21 / Number of stock acquisition rights 255 rights |
| Basis for determining the amount to be paid | Fair value per share calculated using the Black-Scholes model on the allotment date. The periods used for the closing price and average share price, and the discount and premium rates: not disclosed |
| Exercise price | ¥1 per share. Adjustment provisions and floor: Not disclosed |
| Exercise period | Start Date 25 April 2026 / End date 24 April 2056 |
| Number of Stock Acquisition Rights | Total number issued 326 (the number scheduled to be allotted; this may decrease if applications are not submitted, among other circumstances) / Number of unexercised units Not disclosed |
| Transfer restriction period | not disclosed (approval from the Company's Board of Directors is required for any transfer or acquisition by transfer) |
| Conditions for lifting transfer restrictions | The rights may be exercised only within 10 days from the day following the date on which the holder loses all positions as a director. Other conditions are governed by the share acquisition rights allotment agreement. |
| Reason for acquisition without consideration | If the rights become unexercisable before exercise, or if a proposal for a merger, company split, share exchange, share transfer or similar transaction is approved, among other circumstances |
| Categories and Number of Persons Covered | Category Directors of the Company (excluding outside directors and directors who are Audit & Supervisory Committee members) / Number of Employees 3 / Number of allocated stock acquisition rights 71 rights, Category Directors of the Company's subsidiaries (excluding outside directors, Audit & Supervisory Board members and non-executive directors) / Number of Employees 21 / Number of allocated stock acquisition rights 255 rights |
| Total Stock-Based Compensation | Compensation receivables equivalent to the payment amount for the share acquisition rights. Amount: not disclosed |
| Procedures under the Corporate Code of Conduct | Resolved at the Board of Directors meeting held on 8 April 2026. Obtaining an opinion from an independent third party and confirming shareholder intent: not disclosed |
| Impact on Business Performance | The purpose is to strengthen incentives to improve long-term business performance and corporate value. Impact on business performance and financial results: not disclosed |
Items this document does not state (12)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To share with shareholders the benefits and risks of share price movements and provide stronger-than-ever incentives to improve long-term performance and enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.